Viewing Study NCT01812005


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-01-09 @ 2:01 PM
Study NCT ID: NCT01812005
Status: TERMINATED
Last Update Posted: 2018-06-06
First Post: 2013-03-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Sponsor: Ohio State University Comprehensive Cancer Center
Organization: